Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have similar levels of certain proteins compared to women without PCOS, and these proteins don't independently cause PCOS.

Androgens may block hair growth signals, targeting this could treat hair loss.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Testosterone is crucial for development, growth, and various body functions in mammals.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Gene mutations can cause problems in male genital development.

Long-term diabetes is linked to lower prostate cancer risk.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

PRP improves hair thickness for both genders, but only increases hair density in men.

Adding platelet-rich plasma improves hair density and thickness in androgenetic alopecia.

Women with PCOS have lower amylin levels, which are not related to their body weight.

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Finasteride metabolites found in pigs match human studies, making pigs a valid model for human drug research.

Lower SHBG levels may increase the risk of PCOS.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

Women with PCOS have heart-related issues not because of obesity, but due to insulin resistance and low adiponectin levels.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.

Vegetarian Indian women with PCOS have higher inflammation levels than non-vegetarians.

High levels of TNF-α may contribute to obesity and insulin resistance in PCOS, but not due to the C850T genetic variation.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

Evening primrose oil significantly improves hormone levels and reduces BMI and cholesterol in women with PCOS.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.